vs
Side-by-side financial comparison of Crexendo, Inc. (CXDO) and OCULAR THERAPEUTIX, INC (OCUL). Click either name above to swap in a different company.
Crexendo, Inc. is the larger business by last-quarter revenue ($18.1M vs $13.3M, roughly 1.4× OCULAR THERAPEUTIX, INC). Crexendo, Inc. runs the higher net margin — 6.7% vs -488.0%, a 494.7% gap on every dollar of revenue. On growth, Crexendo, Inc. posted the faster year-over-year revenue change (11.2% vs -22.4%). Over the past eight quarters, Crexendo, Inc.'s revenue compounded faster (12.4% CAGR vs -5.3%).
Crexendo, Inc. is a U.S.-headquartered cloud communications technology provider. It delivers unified communications as a service (UCaaS), contact center solutions, business VoIP services, and collaborative work tools, primarily catering to small and medium-sized enterprises operating in the North American market.
Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.
CXDO vs OCUL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.1M | $13.3M |
| Net Profit | $1.2M | $-64.7M |
| Gross Margin | — | 88.0% |
| Operating Margin | 6.3% | -526.5% |
| Net Margin | 6.7% | -488.0% |
| Revenue YoY | 11.2% | -22.4% |
| Net Profit YoY | 140.2% | -33.6% |
| EPS (diluted) | $0.03 | $-0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.1M | $13.3M | ||
| Q3 25 | $17.5M | $14.5M | ||
| Q2 25 | $16.6M | $13.5M | ||
| Q1 25 | $16.1M | $10.7M | ||
| Q4 24 | $16.2M | $17.1M | ||
| Q3 24 | $15.6M | $15.4M | ||
| Q2 24 | $14.7M | $16.4M | ||
| Q1 24 | $14.3M | $14.8M |
| Q4 25 | $1.2M | $-64.7M | ||
| Q3 25 | $1.4M | $-69.4M | ||
| Q2 25 | $1.2M | $-67.8M | ||
| Q1 25 | $1.2M | $-64.1M | ||
| Q4 24 | $507.0K | $-48.4M | ||
| Q3 24 | $148.0K | $-36.5M | ||
| Q2 24 | $588.0K | $-43.8M | ||
| Q1 24 | $434.0K | $-64.8M |
| Q4 25 | — | 88.0% | ||
| Q3 25 | — | 87.8% | ||
| Q2 25 | — | 85.6% | ||
| Q1 25 | — | 88.2% | ||
| Q4 24 | — | 92.8% | ||
| Q3 24 | — | 89.9% | ||
| Q2 24 | — | 90.8% | ||
| Q1 24 | — | 91.0% |
| Q4 25 | 6.3% | -526.5% | ||
| Q3 25 | 7.5% | -472.3% | ||
| Q2 25 | 6.7% | -502.6% | ||
| Q1 25 | 7.2% | -597.5% | ||
| Q4 24 | 3.9% | -296.1% | ||
| Q3 24 | 0.9% | -298.2% | ||
| Q2 24 | 3.9% | -265.1% | ||
| Q1 24 | 3.4% | -214.0% |
| Q4 25 | 6.7% | -488.0% | ||
| Q3 25 | 8.3% | -477.3% | ||
| Q2 25 | 7.4% | -503.9% | ||
| Q1 25 | 7.3% | -598.7% | ||
| Q4 24 | 3.1% | -283.3% | ||
| Q3 24 | 0.9% | -236.6% | ||
| Q2 24 | 4.0% | -266.3% | ||
| Q1 24 | 3.0% | -438.9% |
| Q4 25 | $0.03 | $-0.27 | ||
| Q3 25 | $0.05 | $-0.38 | ||
| Q2 25 | $0.04 | $-0.39 | ||
| Q1 25 | $0.04 | $-0.38 | ||
| Q4 24 | $0.03 | $-0.25 | ||
| Q3 24 | $0.00 | $-0.22 | ||
| Q2 24 | $0.02 | $-0.26 | ||
| Q1 24 | $0.01 | $-0.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $737.1M |
| Total DebtLower is stronger | $114.0K | — |
| Stockholders' EquityBook value | $63.8M | $654.3M |
| Total Assets | $77.7M | $808.1M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $737.1M | ||
| Q3 25 | — | $344.8M | ||
| Q2 25 | — | $391.1M | ||
| Q1 25 | — | $349.7M | ||
| Q4 24 | — | $392.1M | ||
| Q3 24 | — | $427.2M | ||
| Q2 24 | — | $459.7M | ||
| Q1 24 | — | $482.9M |
| Q4 25 | $114.0K | — | ||
| Q3 25 | $236.0K | — | ||
| Q2 25 | $356.0K | — | ||
| Q1 25 | $475.0K | — | ||
| Q4 24 | $592.0K | — | ||
| Q3 24 | $709.0K | — | ||
| Q2 24 | $823.0K | — | ||
| Q1 24 | $937.0K | — |
| Q4 25 | $63.8M | $654.3M | ||
| Q3 25 | $61.3M | $258.2M | ||
| Q2 25 | $58.3M | $305.9M | ||
| Q1 25 | $55.2M | $265.9M | ||
| Q4 24 | $51.4M | $315.3M | ||
| Q3 24 | $49.5M | $352.0M | ||
| Q2 24 | $48.2M | $377.7M | ||
| Q1 24 | $46.8M | $408.0M |
| Q4 25 | $77.7M | $808.1M | ||
| Q3 25 | $76.0M | $410.9M | ||
| Q2 25 | $71.4M | $451.3M | ||
| Q1 25 | $67.4M | $405.9M | ||
| Q4 24 | $64.9M | $457.9M | ||
| Q3 24 | $62.3M | $490.4M | ||
| Q2 24 | $59.6M | $517.1M | ||
| Q1 24 | $57.5M | $538.9M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 0.01× | — | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.02× | — | ||
| Q1 24 | 0.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.3M | $-54.2M |
| Free Cash FlowOCF − Capex | — | $-57.1M |
| FCF MarginFCF / Revenue | — | -430.9% |
| Capex IntensityCapex / Revenue | 0.0% | 21.4% |
| Cash ConversionOCF / Net Profit | 1.93× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-216.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.3M | $-54.2M | ||
| Q3 25 | $4.4M | $-50.7M | ||
| Q2 25 | $1.3M | $-55.2M | ||
| Q1 25 | $1.2M | $-44.7M | ||
| Q4 24 | $2.2M | $-39.4M | ||
| Q3 24 | $1.6M | $-36.6M | ||
| Q2 24 | $2.7M | $-24.8M | ||
| Q1 24 | $-166.0K | $-33.9M |
| Q4 25 | — | $-57.1M | ||
| Q3 25 | — | $-56.7M | ||
| Q2 25 | $1.3M | $-56.5M | ||
| Q1 25 | — | $-46.6M | ||
| Q4 24 | $2.1M | $-39.6M | ||
| Q3 24 | — | $-36.6M | ||
| Q2 24 | — | $-25.5M | ||
| Q1 24 | — | $-34.1M |
| Q4 25 | — | -430.9% | ||
| Q3 25 | — | -390.0% | ||
| Q2 25 | 7.7% | -419.7% | ||
| Q1 25 | — | -435.6% | ||
| Q4 24 | 13.2% | -232.0% | ||
| Q3 24 | — | -237.6% | ||
| Q2 24 | — | -155.4% | ||
| Q1 24 | — | -231.1% |
| Q4 25 | 0.0% | 21.4% | ||
| Q3 25 | 0.0% | 41.2% | ||
| Q2 25 | 0.1% | 9.3% | ||
| Q1 25 | 0.0% | 18.1% | ||
| Q4 24 | 0.2% | 1.2% | ||
| Q3 24 | 0.0% | 0.6% | ||
| Q2 24 | 0.0% | 4.5% | ||
| Q1 24 | 0.0% | 1.7% |
| Q4 25 | 1.93× | — | ||
| Q3 25 | 3.05× | — | ||
| Q2 25 | 1.05× | — | ||
| Q1 25 | 1.06× | — | ||
| Q4 24 | 4.29× | — | ||
| Q3 24 | 10.95× | — | ||
| Q2 24 | 4.51× | — | ||
| Q1 24 | -0.38× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CXDO
| Services | $8.6M | 48% |
| Software Solution Segment | $8.3M | 46% |
| Products | $1.1M | 6% |
OCUL
Segment breakdown not available.
